Canaccord Genuity Starts Alnylam Pharmaceuticals (ALNY) at Buy
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $265.68 -0.64%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Buy rating and a price target of $160.00.
For an analyst ratings summary and ratings history on Alnylam Pharmaceuticals click here. For more ratings news on Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $94.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Vishay Intertechnology (VSH) at Buy
- Morgan Stanley Resumes Deutsche Boerse AG (DB1:GR) (DBOEY) at Equalweight
- Rosenblatt Assumes Broadcom Limited (AVGO) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
